Literature DB >> 1091238

Early events in myxovirus replication: immunofluorescent spots.

O Haller, A Bucher-Nurminen, J Lindenmann.   

Abstract

Indirect immunofluorescent staining of Ehrlich ascites tumor cells infected with two influenza A strains, WSA (HON1) and TUR (Hav1 Nav3), revealed early fluorescent spots which became detectable in the cytoplasm within 30 minutes of infection, before the nucleoprotein antigen appeared in the nucleus. These spots seemed to be linked to some structural antigen of the virus not identical with hemagglutinin, neuraminidase, or nucleoprotein. Their formation was not inhibited by actinomycin, p-fluorophenylalanine or amantadine in concentrations sufficient to block viral replication; amantadine led to an altered time course of spot evolution and to the emergence of coarser spots. The exact serologic specificity of early spots remains to be worked out but appears to differ from that of known influenza A antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091238     DOI: 10.1007/bf01317814

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

1.  The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 1. Studies employing a low multiplicity of infection in beef embryo kidney cells.

Authors:  O A HOLTERMANN; W D HILLIS; M A MOFFAT
Journal:  Acta Pathol Microbiol Scand       Date:  1960

2.  The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. 2. Studies employing a high multiplicity of infection in beef embryo kidney cells.

Authors:  M A MOFFAT; O A HOLTERMANN; W D HILLIS
Journal:  Acta Pathol Microbiol Scand       Date:  1960

3.  Immunofluorescence of abortive and complete infections by influenza A virus in hamster BHK21 cells and mouse L cells.

Authors:  K B Fraser
Journal:  J Gen Virol       Date:  1967-01       Impact factor: 3.891

4.  Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion.

Authors:  G C Schild; H G Pereira
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

5.  Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics.

Authors:  C Scholtissek; R Rott
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

6.  New virus-specific antigens in cells infected with influenza virus.

Authors:  N J Dimmock
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

7.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

8.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

9.  Immunogenicity of egg-grown influenza vaccine: inhibition by immunization of recipients with host antigen.

Authors:  J Lindenmann
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Studies of influenza virus infection in the chick embryo using fluorescent antibody.

Authors:  B K WATSON; A H COONS
Journal:  J Exp Med       Date:  1954-05-01       Impact factor: 14.307

View more
  1 in total

1.  A mouse hepatotropic variant of influenza virus.

Authors:  O Haller
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.